Csl112 has statistically significant benefit for the (large) subset with elevated cholesterol. Watch this interview.
https://x.com/pcronline/status/1776899697979908480?s=46&t=gIEfHki59HGaX1ECB5cPoA
only a matter of time until csl get all the data together to submit this for registration for the (large) population for which it is shown effective.
Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-47
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$286.84 |
Change
2.845(1.00%) |
Mkt cap ! $138.4B | |||
| Open | High | Low | Value | Volume |
| $286.36 | $287.10 | $285.12 | $18.78M | 65.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22 | $286.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.92 | 5 | 2 |
View Market Depth
| Last trade - 12.08pm 06/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |